Prostate cancer remains the most frequently diagnosed malignant tumor among men worldwide.
In a recent episode of Hadassah On Call, Dr. Ofer Gofrit, chair of the Urology Department at the Hadassah Medical Organization, offered in-depth insights into the disease.
He covered its prevalence, key risk factors, and the wide range of treatment options available today.
Despite its seriousness, Dr. Gofrit emphasized that prostate cancer often develops slowly, allowing time for early diagnosis and careful management.
Early Detection and the Role of Screening
According to Dr. Gofrit, early screening is a crucial step in reducing mortality from prostate cancer.
He recommends initiating screening at around 45 years of age, particularly for men with a family history of the disease.
“Prostate cancer is a slow-growing tumor. There is time to diagnose it early,” he notes.
A father or grandfather with prostate cancer significantly increases one’s genetic risk, underscoring the importance of vigilance in these families.
Early detection through screening and the PSA test provides a window of opportunity for effective management before the cancer becomes aggressive.
Active Surveillance: A Balanced Approach
Not every prostate cancer case requires immediate treatment.
Dr. Gofrit highlights that active surveillance—regular monitoring without aggressive intervention—has become a standard practice.
This approach aims to prevent unnecessary overtreatment, which was common in the past.
Men under active surveillance undergo periodic PSA tests, imaging, and biopsies to track disease progression.
This careful observation helps ensure that only those who truly need intervention receive it at the right time.
Lifestyle Choices That Protect the Prostate
Prevention begins with everyday habits. Dr. Gofrit stresses that “whatever is good for the heart is also good for the prostate.”
He advocates for a balanced diet, regular aerobic exercise, and maintaining a healthy weight.
Scientific studies have shown that overweight men face a higher risk of developing prostate cancer.
Healthy living not only helps prevent the disease but can also improve treatment outcomes and recovery.
PSA Testing and Diagnostic Advances
Dr. Gofrit discusses the advantages and limitations of the PSA (Prostate-Specific Antigen) test.
While PSA testing remains a cornerstone of early detection, it can sometimes lead to false positives or overdiagnosis.
To address this, researchers are developing more precise blood-based biomarkers and advanced imaging techniques to improve diagnostic accuracy and reduce unnecessary biopsies.
These advancements are paving the way for more personalized and effective prostate cancer care.
Treatment Options and Their Impact
When treatment becomes necessary, options include surgery, radiation therapy, and hormonal therapy.
Dr. Gofrit explains that each treatment plan is tailored to the patient’s specific condition, age, and overall health.
He also discusses how treatment can affect a man’s daily life and sexual health, and how rehabilitation programs can help manage side effects.
Furthermore, patients are monitored for signs of recurrence, ensuring long-term follow-up and support.
Beyond Cancer: Broader Health Connections
In addition to prostate cancer, Dr. Gofrit touches on fascinating links between bladder cancer, the BCG vaccine, and potential implications for Alzheimer’s disease.
These insights reflect how urological research continues to intersect with broader medical discoveries, expanding our understanding of immune system function and aging.
Related topics
Experts Urge Early PSA Test for Better Cancer Management
Experts Link Keto Diet Success to the ‘Add, Don’t Subtract’ Mindset”
The 6 Best Clippers for Men Delivering Speed, Precision and Performance
